Cure for certain cancers is ‘realistic’ goal in next decade, pharma lead says

A cure for crab could beryllium connected the skyline successful the adjacent decade, according to experts.

During the WSJ Leadership Institute CEO Summit successful London past week, Johnson & Johnson Chairman and CEO Joaquin Duato reflected connected the pharmaceutical company’s projections connected the aboriginal of crab treatment.

In the adjacent 10 years, the extremity is to "try to destruct cancer," Duato shared.

NEW CANCER VACCINE DELIVERS STUNNING RESULT AGAINST ONE OF THE DEADLIEST SKIN CANCERS

"That’s a precocious goal, and we are already making important advancement successful definite cancers," helium said.

Duato utilized aggregate myeloma arsenic an example, noting that the beingness expectancy is presently 10 years, erstwhile it was antecedently "only azygous years."

Joaquin Duato, president and CEO of Johnson and Johnson, speaks astatine the Punchbowl News Conference astatine Union Station connected March 10, 2026, successful Washington, DC. (Heather Diehl/Getty Images)

"We person treatments present that utilize your ain immune strategy to onslaught the cancer," helium said astatine the summit. "For patients who were already going into hospice, truthful they didn’t person immoderate different alternative, they are [at] much than 5 years, with a azygous administration, successful remission. That [is] spectacular."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"When patients spot that, they cannot judge that due to the fact that they person been coming to the infirmary each week [for] a decade, having aggregate therapies."

The extremity is to "try to destruct cancer" successful the adjacent 10 years, the pharmaceutical enforcement said. (iStock)

According to Duato, Johnson & Johnson is moving to recognize the biology of crab maturation and to formulate caller technologies to code it.

"It’s realistic to judge that we are going to cure definite cancers, and immoderate others we’re going to crook into chronic diseases," helium predicted.

CLICK HERE FOR MORE HEALTH STORIES

"Cancer is an important happening – I cannot deliberation astir anybody who has not been touched by cancer," helium went on. "But determination are galore different opportunities for america to really beforehand science, to code precise important societal problems."

Duato called retired dementia arsenic different "important problem" successful request of a solution.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

He predicted that beingness expectancy, which has risen steadily implicit the past century, volition proceed to summation arsenic longevity technologies and solutions advance, improving prime of beingness on the way.

Duato commented that J&J has been optimistic astir the relation artificial quality volition play successful the aboriginal of healthcare, calling it a "force multiplier."

Biomarkers and AI tin assistance with the earlier diagnosis of cancer, arsenic good arsenic a much precocious and personalized attack to surgery, a doc noted. (iStock)

Fox News elder aesculapian expert Dr. Marc Siegel agreed with Duato's outlook connected the aboriginal of crab care, noting that definite cancers volition crook into chronic diseases portion others volition find outright cures.

"Advances [will be] based connected the usage of AI to assistance usher targeted treatments with expanding cognition of crab mutations and however to people them," helium predicted, speaking to Fox News Digital.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Siegel added that biomarkers and AI tin assistance with earlier diagnoses, arsenic good arsenic a much precocious and personalized attack to surgery.

J&J precocious acquired Firefly Bio, a biotech steadfast that produces drugs that participate crab cells to "target definite proteins that incorporate hard to dainty cistron mutations," the doc added.